Rahul Mojidra

机构：The University of Texas at San Antonio Health Science Center, Homi Bhabha National Institute, Urology San Antonio, Advanced Centre for Treatment, Research and Education in Cancer, Mays Cancer Center at UT Health San Antonio, The University of Texas at San Antonio · ORCID：0000-0002-7103-9784

发表论文 19 篇 · 总被引 59 次 · h-index 2

代表论文

• Promotion of DNA end resection by BRCA1–BARD1 in homologous recombination (2024 · Nature · 被引 39)
• DNA Fingerprint Analysis of Raman Spectra Captures Global Genomic Alterations in Imatinib-Resistant Chronic Myeloid Leukemia: A Potential Single Assay for Screening Imatinib Resistance (2021 · Cells · 被引 16)
• Genomic analysis identifies an incipient signature to forecast imatinib resistance before start of treatment in patients with chronic myeloid leukemia (2025 · Advances in Biomarker Sciences and Technology · 被引 2)
• Comparison of marmoset and human FSH using synthetic peptides of the β‐subunit L2 loop region and anti‐peptide antibodies (2016 · Journal of Peptide Science · 被引 2)
• Anionic lipids regulate PLCβ membrane recruitment (2026 · bioRxiv (Cold Spring Harbor Laboratory))
• Reduced levels of ITGB1 cause activation of p38MAPK-ERK-LYN axis of BCR::ABL1 signaling despite inactivation of the oncoprotein by imatinib – novel resistance mechanism in blast crisis of chronic myeloid leukemia unraveled (2026 · Cell Communication and Signaling)